VRTX
VRTX
NASDAQ · Biotechnology

Vertex Pharmaceuticals Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$494.74
-4.91 (-0.98%)
Analyst Consensus
Strong Buy
40
Analysts
Very High
Coverage
Buy 33 83%
Hold 6 15%
Sell 1 3%
Price Target
Analyst Price Target -11.4% upside
Low Target $313.95
Average Target $438.34
High Target $454.41
Current Price $494.74
Current
$494.74
Target
$438.34
$313.95 $438.34 avg $454.41
Scenario Analysis
Bear Case
$313.95
-36.5%
Low target
Base Case
$438.34
-11.4%
Avg target
Bull Case
$454.41
+-8.2%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$507.92
-2.6% from high
52-Week Low
$362.50
+36.5% from low
50-Day SMA
$461.14
+7.3% vs SMA
200-Day SMA
$435.10
+13.7% vs SMA
RSI (14)
47.3
Neutral
Target vs 52W High
$438.34
-13.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.1%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.5%